Why Do Michigan Patients Recommend Doctors Who Prescribe Wegovy
The SURMOUNT-1 trial (N=2,539) reported a vomiting rate of 12.2% for tirzepatide 15 mg, lower than the 24.8% seen with semaglutide 2.4 mg in STEP 1, although cross-trial comparisons have significant limitations [16]
Understanding the differences between these medicationsand your own genetic predispositionscan help you make an informed decision about whether switching makes sense for your weight loss journey
All content on this page is produced by the Practice Plus Group digital content team and clinically reviewed by consultant specialists to ensure accuracy, patient safety, and alignment with current UK clinical best practice
Understanding Nausea and GLP-1 Medications GLP-1 (glucagon-like peptide-1) receptor agonists work by mimicking a natural hormone that slows digestion, increases insulin secretion and helps regulate appetite
Our patients have had monumental weight loss results